Tripeptidyl-peptidase I in health and disease

References

Altorjay, A., Paal, B., Sohar, N., Kiss, J., Szanto, I., and Sohar, I. (2005). Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus. World J. Gastroenterol.11, 5751–5756.10.3748/wjg.v11.i37.5751Search in Google Scholar

Andersen, K.J. and McDonald, J.K. (1987). Subcellular distribution of renal tripeptide-releasing exopeptidases active on collagen-like sequences. Am. J. Physiol.252, F890–F898.10.1152/ajprenal.1987.252.5.F890Search in Google Scholar

Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O.R., and Fan, J.Q. (2000). In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives. Eur. J. Biochem.267, 4179– 4186.10.1046/j.1432-1327.2000.01457.xSearch in Google Scholar

Bernardini, F. and Warburton, M.J. (2001). The substrate range of tripeptidyl-peptidase I. Eur. J. Paediatr. Neurol.5 (Suppl. A), 69–72.10.1053/ejpn.2000.0438Search in Google Scholar

Bienkowski, M.J. and Conrad, H.E. (1984). Kinetics of proteoheparan sulfate synthesis, secretion, endocytosis, and catabolism by a hepatocyte cell line J. Biol. Chem.259, 12989–12996.10.1016/S0021-9258(18)90645-9Search in Google Scholar

Brady, R.O. (2006). Enzyme replacement for lysosomal diseases. Annu. Rev. Med.57, 283–296.10.1146/annurev.med.57.110104.115650Search in Google Scholar PubMed

Chen, R., Fearnley, I.M., Palmer, D.N., and Walker, J.E. (2004). Lysine 43 is trimethylated in subunit C from bovine mitochondrial ATP synthase and in storage bodies associated with Batten disease. J. Biol. Chem.279, 21883–21887.10.1074/jbc.M402074200Search in Google Scholar PubMed

Crystal, R.G., Sondhi, D., Hackett, N.R., Kaminsky, S.M., Worgall, S., Stieg, P., Souweidane, M., Hosain, S., Heier, L., Ballon, D., et al. (2004). Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis. Hum. Gene Ther.15, 1131–1154.Search in Google Scholar

Dekaban, A.S. (1978). Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann. Neurol.4, 345–356.10.1002/ana.410040410Search in Google Scholar PubMed

Du, P.G., Kato, S., Li, Y.H., Maeda, T., Yamane, T., Yamamoto, S., Fujiwara, M., Yamamoto, Y., Nishi, K., and Ohkubo, I. (2001). Rat tripeptidyl peptidase I: molecular cloning, functional expression, tissue localization and enzymatic characterization. Biol. Chem.382, 1715–1725.10.1515/BC.2001.207Search in Google Scholar PubMed

Elleder, M., Sokolova, J., and Hrebicek, M. (1997). Follow-up study of subunit C of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol. (Berl.)93, 379–390.10.1007/s004010050629Search in Google Scholar PubMed

Ezaki, J., Tanida, I., Kanehagi, N., and Kominami, E. (1999). A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit C of ATP synthase. J. Neurochem.72, 2573–2582.10.1046/j.1471-4159.1999.0722573.xSearch in Google Scholar PubMed

Ezaki, J., Takeda-Ezaki, M., Oda, K., and Kominami, E. (2000). Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis. Biochem. Biophys. Res. Commun.268, 904–908.10.1006/bbrc.2000.2207Search in Google Scholar PubMed

Gaillard, P.J., Visser, C.C., and de Boer, A.G. (2005). Targeted delivery across the blood-brain barrier. Expert Opin. Drug Deliv.2, 299–309.10.1517/17425247.2.2.299Search in Google Scholar PubMed

Golabek, A.A., Kida, E., Walus, M., Wujek, P., Mehta, P., and Wisniewski, K.E. (2003). Biosynthesis, glycosylation and enzymatic processing in vivo of human tripeptydyl-peptidase I. J. Biol. Chem.278, 7135–7145.10.1074/jbc.M211872200Search in Google Scholar PubMed

Golabek, A.A., Wujek, P., Walus, M., Bieler, S., Soto, C., Wisniewski, K.E., and Kida, E. (2004). Maturation of human tripeptidyl-peptidase I in vitro. J. Biol. Chem.279, 31058–31067.10.1074/jbc.M400700200Search in Google Scholar PubMed

Golabek, A.A., Walus, M., Wisniewski, K.E., and Kida, E. (2005). Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo. J. Biol. Chem.280, 7550–7561.10.1074/jbc.M412047200Search in Google Scholar PubMed

Guo, H., Wlodawer, A., and Guo, H. (2005). A general acid-base mechanism for the stabilization of a tetrahedral adduct in a serine-carboxyl peptidase: a computational study. J. Am. Chem. Soc.127, 15662–15663.10.1021/ja0520565Search in Google Scholar PubMed

Hackett, N.R., Redmond, D.E., Sondhi, D., Giannaris, E.L., Vassallo, E., Stratton, J., Qiu, J., Kaminsky, S.M., Lesser, M.L., Fisch, G.S., et al. (2005). Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates. Hum. Gene Ther.16, 1484–1503.10.1089/hum.2005.16.1484Search in Google Scholar PubMed

Haskell, R.E., Hughes, S.M., Chiorini, J.A,. Alisky, J.M., and Davidson, B.L. (2003). Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther.10, 34–42.10.1038/sj.gt.3301843Search in Google Scholar PubMed

Helenius, A. and Aebi, M. (2004). Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem.73, 1019–1049.10.1146/annurev.biochem.73.011303.073752Search in Google Scholar PubMed

Iozzo, R.V. (1998). Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem.67, 609–652.10.1146/annurev.biochem.67.1.609Search in Google Scholar

Jeyakumar, M., Dwek, R.A., Butters, T.D., and Platt, F.M. (2005). Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci.6, 713–725.10.1038/nrn1725Search in Google Scholar

Junaid, M.A. and Pullarkat, R.K. (1999). Increased brain lysosomal pepstatin-insensitive proteinase activity in patients with neurodegenerative diseases. Neurosci. Lett.264, 157–160.10.1016/S0304-3940(99)00095-6Search in Google Scholar

Junaid, M.A., Clark, G.M., and Pullarkat, R.K. (2000a). A lysosomal pepstatin-insensitive proteinase as a novel biomarker for breast carcinoma. Int. J. Biol. Markers15, 129–134.10.1177/172460080001500201Search in Google Scholar

Junaid, M.A., Wu, G., and Pullarkat, R.K. (2000b). Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis. J. Neurochem.74, 287–294.10.1046/j.1471-4159.2000.0740287.xSearch in Google Scholar

Kelly, S., Bliss, T.M., Shah, A.K., Sun, G.H., Ma, M., Foo, W.C., Masel, J., Yenari, M.A., Weissman, I.L., Uchida, N., et al. (2004). Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. USA101, 11839–11844.10.1073/pnas.0404474101Search in Google Scholar

Kida, E., Wisniewski, K.E., and Golabek, A.A. (1993). Increased expression of subunit C of mitochondrial ATP synthase in brain tissue from neuronal ceroid lipofuscinoses and mucopolysaccharidosis cases but not in long-term fibroblast cultures. Neurosci. Lett.164, 121–124.10.1016/0304-3940(93)90872-ISearch in Google Scholar

Kida, E., Golabek, A.A., and Wisniewski, K. (2001a). Cellular pathology and pathogenic aspects of neuronal ceroid lipofuscinoses. Adv. Genet.45, 35–66.10.1016/S0065-2660(01)45003-6Search in Google Scholar

Kida, E., Golabek, A.A., Walus, M., Wujek, P., Kaczmarski, W., and Wisniewski, K.E. (2001b). Distribution of tripeptidyl peptidase I in human tissues under normal and pathological conditions. J. Neuropathol. Exp. Neurol.60, 280–292.10.1093/jnen/60.3.280Search in Google Scholar PubMed

Koike, M., Shibata, M., Ohsawa, Y., Kametaka, S., Waguri, S., Kominami, E., and Uchiyama, Y. (2002). The expression of tripeptidyl peptidase I in various tissues of rats and mice. Arch. Histol. Cytol.65, 219–232.10.1679/aohc.65.219Search in Google Scholar PubMed

Kopan, S., Sivasubramaniam, U., and Warburton, M.J. (2004). The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis. Biochem. Biophys. Res. Commun.319, 58–65.10.1016/j.bbrc.2004.04.142Search in Google Scholar

Kraemer, P.M. (1971). Heparan sulfates of cultured cells. I. Membrane-associated and cell-sap species in Chinese hamster cells. Biochemistry10, 1437–1445.Search in Google Scholar

Kurachi, Y., Oka, A., Itoh, M., Mizuguchi, M., Hayashi, M., and Takashima, S. (2001). Distribution and development of CLN2 protein, the late-infantile neuronal ceroid lipofuscinosis gene product. Acta Neuropathol. (Berl.)102, 20–26.10.1007/s004010000321Search in Google Scholar

Li, Z., Yasuda, Y., Li, W., Bogyo, M., Katz, N., Gordon, R.E., Fields, G.B., and Bromme, D. (2004). Regulation of collagenase activities of human cathepsins by glycosaminoglycans. J. Biol. Chem.279, 5470–5479.10.1074/jbc.M310349200Search in Google Scholar

Lin, L. and Lobel, P. (2001). Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem. J.357, 49–55.10.1042/bj3570049Search in Google Scholar

Lin, L., Sohar, I., Lackland, H., and Lobel, P. (2001). The human CLN2 protein/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J. Biol. Chem.276, 2249–2255.10.1074/jbc.M008562200Search in Google Scholar

Liu, C-G., Sleat, D.E., Donnelly, R.J., and Lobel, P. (1998). Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis. Genomics50, 206–212.10.1006/geno.1998.5328Search in Google Scholar

McDonald, J.K., Hoisington, A.R., and Eisenhauer, D.A. (1985). Partial purification and characterization of an ovarian tripeptidyl peptidase: a lysosomal exopeptidase that sequentially releases collagen-related (Gly-Pro-X) triplets. Biochem. Biophys. Res. Commun.126, 63–71.10.1016/0006-291X(85)90571-6Search in Google Scholar

Mellman, I., Fuchs, R., and Helenius, A. (1986). Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem.55, 663–700.10.1146/annurev.bi.55.070186.003311Search in Google Scholar PubMed

Mikhailenko, I., Kounnas, M.Z., and Strickland, D.K. (1995). Low density lipoprotein receptor-related protein/α2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans. J. Biol. Chem.270, 9543–9549.10.1074/jbc.270.16.9543Search in Google Scholar PubMed

Mortimore, G. (1987). Mechanism and regulation of induced and basal protein degradation in liver. In: Lysosomes: Their Role in Protein Breakdown, H. Glaumann and F.J. Ballard, eds. (New York, USA: Academic Press), pp. 415–444.Search in Google Scholar

Neuwelt, E.A., Howieson, J., Frenkel, E.P., Specht, H.D., Weigel, R., Buchan, C.G., and Hill, S.A. (1986). Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery19, 573–582.10.1227/00006123-198610000-00011Search in Google Scholar PubMed

Ohkuma, S. and Poole, B. (1978). Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA75, 3327–3331.10.1073/pnas.75.7.3327Search in Google Scholar

Oyama, H., Fujisawa, T., Suzuki, T., Dunn, B.M., Wlodawer, A., and Oda, K. (2005). Catalytic residues and substrate specificity of recombinant human tripeptidyl peptidase I (CLN2). J. Biochem. (Tokyo)138, 127–134.10.1093/jb/mvi110Search in Google Scholar

Page, A.E., Fuller, K., Chambers, T.J., and Warburton, M.J. (1993). Purification and characterization of a tripeptidyl peptidase I from human osteoclastomas: evidence for its role in bone resorption. Arch. Biochem. Biophys.306, 354–359.10.1006/abbi.1993.1523Search in Google Scholar

Palmer, D.N., Fearnley, I.M., Walker, J.E., Hall, N.A., Lake, B.D., Wolfe, L.S., Haltia, M., Martinus, R.D., and Jolly, R.D. (1992). Mitochondrial ATP synthase subunit C storage in the ceroid-lipofuscinoses (Batten disease). Am. J. Med. Genet.42, 561–567.10.1002/ajmg.1320420428Search in Google Scholar

Passini, M.A., Dodge, J.C., Bu, J., Yang, W., Zhao, Q., Sondhi, D., Hackett, N.R., Kaminsky, S.M., Mao, Q., Shihabuddin, L.S., et al. (2006). Intracranial delivery of CLN2 reduces brain pathology in a mouse model of classical late infantile neuronal ceroid lipofuscinosis. J. Neurosci.26, 1334–1342.10.1523/JNEUROSCI.2676-05.2006Search in Google Scholar

Rawlings, N.D. and Barrett, A.J. (1994). Families of serine peptidases. Methods Enzymol.244, 19–61.10.1016/0076-6879(94)44004-2Search in Google Scholar

Rawlings, N.D. and Barrett, A.J. (1999). Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis. Biochim. Biophys. Acta1429, 496–500.10.1016/S0167-4838(98)00238-6Search in Google Scholar

Reiland, J. and Rapraeger, A.C. (1993). Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci.105, 1085–1093.10.1242/jcs.105.4.1085Search in Google Scholar PubMed

Robert, J., Auzan, C., Ventura, M.A., and Clauser, E. (2005). Mechanisms of cell-surface rerouting of an ER-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone. J. Biol. Chem.280, 42198–42206.10.1074/jbc.M510180200Search in Google Scholar PubMed

Römisch, K. (2004). A cure for traffic jams: small molecule chaperones in the endoplasmic reticulum. Traffic5, 815–820.10.1111/j.1600-0854.2004.00231.xSearch in Google Scholar PubMed

Schueler, U.H., Kolter, T., Kaneski, C.R., Zirzow, G.C., Sandhoff, K., and Brady R.O. (2004). Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease. J. Inherit. Metab. Dis.27, 649–658.10.1023/B:BOLI.0000042959.44318.7cSearch in Google Scholar

Sharp, J.D., Wheeler, R.B., Lake, B.D., Savukoski, M., Jarvela, I.E., Peltonen, L., Gardiner, R.M., and Williams, R.E. (1997). Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum. Mol. Genet.6, 591–595.10.1093/hmg/6.4.591Search in Google Scholar PubMed

Sleat, D.E., Donnelly, R.J., Lackland H., Liu, C.G., Sohar, I., Pullarkat, R.K., and Lobel, P. (1997). Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science277, 1802–1805.10.1126/science.277.5333.1802Search in Google Scholar PubMed

Sleat, D.E., Gin, R.M., Sohar, I., Wisniewski, K.E., Sklower Brooks, S., Pullarkat, R., Palmer, D.N., Lerner, T.J., Boustany, R.M., Uldall, P., et al. (1999). Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am. J. Hum. Genet.64, 1511–1523.10.1086/302427Search in Google Scholar PubMed PubMed Central

Sleat, D.E., Sohar, I., Gin, R.M., and Lobel, P. (2001). Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis. Eur. J. Paediatr. Neurol.5 (Suppl. A), 57–62.10.1053/ejpn.2000.0436Search in Google Scholar PubMed

Sleat, D.E., Wiseman, J.A., El-Banna, M., Kim, K.H., Mao, Q., Price, S., Macauley, S.L., Sidman, R.L., Shen, M.M., Zhao, Q., et al. (2004). A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J. Neurosci.24, 9117–9126.10.1523/JNEUROSCI.2729-04.2004Search in Google Scholar PubMed PubMed Central

Sohar, N., Sohar, I., and Hammer, H. (2005). Lysosomal enzyme activities: new potential markers for Sjögren's syndrome. Clin. Biochem.38, 1120–1126.10.1016/j.clinbiochem.2005.09.003Search in Google Scholar PubMed

Steinfeld, R., Steinke, H.B., Isbrandt, D., Kohlschutter, A., and Gartner, J. (2004). Mutations in classical late infantile neuronal ceroid lipofuscinosis disrupt transport of tripeptidyl-peptidase I to lysosomes. Hum. Mol. Genet.13, 2483–2491.10.1093/hmg/ddh264Search in Google Scholar PubMed

Suopanki, J., Partanen, S., Ezaki, J., Baumann, M., Kominami, E., and Tyynela J. (2000). Developmental changes in the expression of neuronal ceroid lipofuscinoses-linked proteins. Mol. Genet. Metab.71, 190–194.10.1006/mgme.2000.3071Search in Google Scholar PubMed

Taupin, P. (2006). HuCNS-SC (StemCells). Curr. Opin. Mol. Ther.8, 156–163.Search in Google Scholar

Tian, Y., Sohar, I., Taylor, J.W., and Lobel, P. (2006). Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates. J. Biol. Chem.281, 6559–6572.10.1074/jbc.M507336200Search in Google Scholar PubMed

Tsai, B., Ye, Y., and Rapoport, T.A. (2002). Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat. Rev. Mol. Cell Biol.3, 246–255.10.1038/nrm780Search in Google Scholar

Tsiakas, K., Steinfeld, R., Storch, S., Ezaki, J., Lukacs, Z., Kominami, E., Kohlschutter, A., Ullrich, K., and Braulke, T. (2004). Mutation of the glycosylated asparagine residue 286 in human CLN2 protein results in loss of enzymatic activity. Glycobiology4, 1C–5C.10.1093/glycob/cwh054Search in Google Scholar

Uvebrant, P. and Hagberg, B. (1997). Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics28, 6–8.Search in Google Scholar

Vellodi, A. (2005). Lysosomal storage disorders. Br. J. Haematol.128, 413–431.10.1111/j.1365-2141.2004.05293.xSearch in Google Scholar

Vines, D. and Warburton, M.J. (1998). Purification and characterisation of a tripeptidyl aminopeptidase I from rat spleen. Biochim. Biophys. Acta1384, 233–242.10.1016/S0167-4838(98)00012-0Search in Google Scholar

Waldburg, N., Kahne, T., Reisenauer, A., Rocken, C., Welte, T., and Buhling, F. (2004). Clinical proteomics in lung diseases. Pathol. Res. Pract.200, 147–154.10.1016/j.prp.2004.02.006Search in Google Scholar

Walus, M., Kida, E., Wisniewski, K.E., and Golabek, A.A. (2005). Ser475, Glu272, Asp276, and Asp360 are involved in catalytic activity of human tripeptidyl-peptidase I. FEBS Lett.579, 1383–1388.10.1016/j.febslet.2005.01.035Search in Google Scholar

Wisniewski, K.E., Kaczmarski, A., Kida, E., Connell, F., Kaczmarski, W., Michalewski, M.P., Moroziewicz, D.N., and Zhong, N. (1999). Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol. Genet. Metab.66, 248–252.10.1006/mgme.1999.2814Search in Google Scholar

Wisniewski, K.E., Kida, E., Golabek, A.A., Kaczmarski, W., Connell, F., and Zhong, N. (2001a). Neuronal ceroid lipofuscinosis: classification and diagnosis. Adv. Genet.45, 1–34.10.1016/S0065-2660(01)45002-4Search in Google Scholar

Wisniewski, K.E., Kida, E., Walus, M., Wujek, P., Kaczmarski, W., and Golabek, A.A. (2001b). Tripeptydyl-peptidase I in neuronal ceroid lipofuscinoses and other lysosomal storage disorders. Eur. J. Paediatr. Neurol.5, 73–79.10.1053/ejpn.2000.0439Search in Google Scholar PubMed

Wlodawer, A., Li, M., Gustchina, A., Oyama, H., Dunn, B.M., and Oda, K. (2003a). Structural and enzymatic properties of the sedolisin family of serine-carboxyl peptidases. Acta Biochim. Pol.50, 81–102.10.18388/abp.2003_3716Search in Google Scholar

Wlodawer, A., Durell, S.R., Li, M., Oyama, H., Oda, K. and Dunn, B.M. (2003b). A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct. Biol.3, 8.Search in Google Scholar

Wujek, P., Kida, E., Walus, M., Wisniewski, K.E., and Golabek, A.A. (2004). N-Glycosylation is crucial for folding, trafficking, and stability of human tripeptidyl-peptidase I. J. Biol. Chem.279, 12827–12839.10.1074/jbc.M313173200Search in Google Scholar PubMed

Yoshida, M., Muneyuki, E., and Hisabori, T. (2001). ATP synthase-a marvelous rotary engine of the cell. Nat. Rev. Mol. Cell. Biol.2, 669–677.10.1038/35089509Search in Google Scholar PubMed

Zhong, N., Wisniewski, K.E., Hartikainen, J., Ju, W., Moroziewicz, D.N., McLendon, L., Sklower, Brooks, S.S., and Brown, W.T. (1998). Two common mutations in the CLN2 gene underlie late infantile neuronal ceroid lipofuscinosis. Clin. Genet.54, 234–238.Search in Google Scholar